19) Novo Nordisk 2022 Revenue: Novo Nordisk had a revenue of 176.95 billion DKK ($25.00 billion USD) in 2022, a 25.68 percent increase from 140.80 billion DKK ($22.39 billion USD) in 2021
But Adam estimates that, for someone carrying two copies, the difference could represent around 10% of their expected weight loss which is, on reflection, significant
Although fMRI studies provide valuable non-invasive evidence that GLP-1RA treatment may alter neural responses to food-related cues, fMRI primarily measures blood-oxygen-level-dependent signals as an indirect index of neural activity, and therefore cannot determine whether GLP-1RAs act directly on specific central GLP-1R-expressing neuronal populations or indirectly through changes in peripheral physiology, interoceptive state, gastric emptying, or nausea-related signalling (98)
Primary carnitine deficiency and pivalic acid exposure causing encephalopathy and fatal cardiac events
Several GLP-1 RAs have additional FDA approval for: Heart protection : Dulaglutide [archived link], liraglutide [archived link], and semaglutide [archived link] have been proven to prevent strokes and heart attacks in people with risk factors, such as diabetes or obesity
Baseline characteristics of the patient population in the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus (SAVOR)-TIMI 53 trial